These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

767 related items for PubMed ID: 19731119

  • 21. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
    Bots ML, Evans GW, Riley W, McBride KH, Paskett ED, Helmond FA, Grobbee DE, OPAL Investigators.
    Eur Heart J; 2006 Mar; 27(6):746-55. PubMed ID: 16415304
    [Abstract] [Full Text] [Related]

  • 22. Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women.
    Valdivia I, Campodónico I, Tapia A, Capetillo M, Espinoza A, Lavín P.
    Fertil Steril; 2004 Mar; 81(3):617-23. PubMed ID: 15037411
    [Abstract] [Full Text] [Related]

  • 23. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.
    Nijland EA, Weijmar Schultz WC, Nathorst-Boös J, Helmond FA, Van Lunsen RH, Palacios S, Norman RJ, Mulder RJ, Davis SR, LISA study investigators.
    J Sex Med; 2008 Mar; 5(3):646-56. PubMed ID: 18304284
    [Abstract] [Full Text] [Related]

  • 24. Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B.
    Castelo-Branco C, Casals E, Figueras F, Sanjuan A, Vicente JJ, Balasch J, Vanrell JA.
    Menopause; 1999 Mar; 6(2):92-7. PubMed ID: 10374214
    [Abstract] [Full Text] [Related]

  • 25. Effects of different postmenopausal hormone therapy regimens on cerebral blood flow and cognitive functions.
    Guvenal T, Durna A, Erden O, Guvenal F, Cetin M, Cetin A.
    Adv Ther; 2009 Aug; 26(8):805-11. PubMed ID: 19672567
    [Abstract] [Full Text] [Related]

  • 26. Effect of tibolone on sexual function in late postmenopausal women.
    Kamenov ZA, Todorova MK, Christov VG.
    Folia Med (Plovdiv); 2007 Aug; 49(1-2):41-8. PubMed ID: 18018469
    [Abstract] [Full Text] [Related]

  • 27. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
    Sarrel P, Dobay B, Wiita B.
    J Reprod Med; 1998 Oct; 43(10):847-56. PubMed ID: 9800666
    [Abstract] [Full Text] [Related]

  • 28. Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality.
    Genazzani AR, Stomati M, Valentino V, Pluchino N, Pot E, Casarosa E, Merlini S, Giannini A, Luisi M.
    Climacteric; 2011 Dec; 14(6):661-8. PubMed ID: 21942655
    [Abstract] [Full Text] [Related]

  • 29. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M, Akan P, Dogan E, Karas C, Saygili U, Posaci C.
    Maturitas; 2006 Feb 20; 53(3):252-9. PubMed ID: 15990257
    [Abstract] [Full Text] [Related]

  • 30. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
    Dimitrakakis C, Keramopoulos D, Vourli G, Gaki V, Bredakis N, Keramopoulos A.
    Climacteric; 2005 Dec 20; 8(4):342-51. PubMed ID: 16390769
    [Abstract] [Full Text] [Related]

  • 31. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
    Reginster JY.
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct 20; 31(6):541-9. PubMed ID: 12407324
    [Abstract] [Full Text] [Related]

  • 32. Women with low libido: correlation of decreased androgen levels with female sexual function index.
    Turna B, Apaydin E, Semerci B, Altay B, Cikili N, Nazli O.
    Int J Impot Res; 2005 Oct 20; 17(2):148-53. PubMed ID: 15592425
    [Abstract] [Full Text] [Related]

  • 33. Nitric oxide in postmenopausal women taking three different HRT regimens.
    Kesim MD, Aydin Y, Erdemir M, Atis A.
    Maturitas; 2005 Jan 10; 50(1):52-7. PubMed ID: 15590214
    [Abstract] [Full Text] [Related]

  • 34. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
    Gregersen N, Jensen PT, Giraldi AE.
    Dan Med Bull; 2006 Aug 10; 53(3):349-53. PubMed ID: 17092454
    [Abstract] [Full Text] [Related]

  • 35. Effects of long-term tibolone treatment on nuclear sex steroid hormone receptors and G-protein-coupled estrogen receptor-1 expression in the macaque uterus.
    Hulchiy M, Zhang H, Cline JM, Hirschberg AL, Sahlin L.
    Menopause; 2012 Mar 10; 19(3):332-8. PubMed ID: 22027943
    [Abstract] [Full Text] [Related]

  • 36. The effect of tibolone versus 17beta-estradiol on climacteric symptoms in women with surgical menopause: a randomized, cross-over study.
    Somunkiran A, Erel CT, Demirci F, Senturk ML.
    Maturitas; 2007 Jan 20; 56(1):61-8. PubMed ID: 16831525
    [Abstract] [Full Text] [Related]

  • 37. The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.
    Skouby SO, Sidelmann JJ, Nilas L, Gram J, Jespersen J.
    Climacteric; 2008 Jan 20; 11(6):489-97. PubMed ID: 18991076
    [Abstract] [Full Text] [Related]

  • 38. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P.
    Arch Gynecol Obstet; 2006 Aug 20; 274(5):289-96. PubMed ID: 16810536
    [Abstract] [Full Text] [Related]

  • 39. A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
    Skouby SO, Sidelmann JJ, Nilas L, Jespersen J.
    Hum Reprod; 2007 Apr 20; 22(4):1186-91. PubMed ID: 17204528
    [Abstract] [Full Text] [Related]

  • 40. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA, Osmanağaoğlu S, Osmanağaoğlu T, Okumuş B, Bozkaya H.
    Fertil Steril; 2005 Aug 20; 84(2):384-93. PubMed ID: 16084879
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.